<h4>Background</h4>Interleukin-33 (IL-33) and its receptor Suppression of tumorigenicity 2 (ST2), along with IL-10 and IFN-<i>γ</i>, exert contrasting roles in tumor growth, immune evasion, and host defense. This evidence concerns the gene IL33 and neoplasm.